Arla Foods Ingredients Peptigen IF-3080 for infant formula

Thursday, 06 April, 2023 | Supplied by: Arla Foods Ingredients

Arla Foods Ingredients Peptigen IF-3080 protein hydrolysates for infant formula has received final EU approval. The product has been deemed safe and suitable for use in formulas and follow-on formulas in the EU.

Now the product has been included in the Commission Delegated Regulation (EU) 2016/7 — the final step necessary for it to be sold across the EU.

Online: Arla Foods Ingredients

GoodMills Innovation GOOD NatureRelax clean-label baking ingredient

The GoodMills Innovation GOOD NatureRelax is a clean-label baking ingredient based on wheat germ...

Prosur Get It Natural Toolbox natural ingredient solutions

Food-biotech company Prosur has developed a toolkit of natural ingredient solutions that is...

ADM Fibersol dietary fibre ingredient

ADM has announced that its dietary fibre ingredient Fibersol has now been approved by the...

Content from other channels on our network

70+ tackle eight high-pressure emergency scenarios

Safe Work Australia releases guidance on managing AI risks

$90K fine after grout gun left apprentice with 5% vision

The glove paradox: why procurement should buy hand-protection outcomes, not SKUs

Australian CDC provides doctors with updated silica dust guidance

The Organisations That Will Lead This Sector in Five Years, Are Making Different Decisions Right Now.

Social media behind almost half of racism and discrimination complaints, Ahpra says

OTs, medical students respond to Commonwealth Prac Payment expansion

HIC returns to Sydney in August

New ACMA SMS rules now in force — could patients be missing vital updates?

Antimicrobial resistance in children rises globally — 100K+ samples reveal

Robotic laboratory to fast-track drug invention, trials and commercialisation

Professor Girish Dwivedi wins 2026 WA Pearcey Entrepreneur of the Year Award

Microscopic life is mining decades-old toxic waste

TGA acts on melatonin imports with infringement notices totalling $99K